| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |